Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares OutstandingShares Outstanding
Ratios

Acro Biomedical (ACBM) Leases (2019 - 2025)

Acro Biomedical has reported Leases over the past 7 years, most recently at $13651.0 for Q2 2025.

  • Quarterly results put Leases at $13651.0 for Q2 2025, down 65.66% from a year ago — trailing twelve months through Jun 2025 was $13651.0 (down 65.66% YoY), and the annual figure for FY2024 was $26898.0, down 48.5%.
  • Leases for Q2 2025 was $13651.0 at Acro Biomedical, down from $20324.0 in the prior quarter.
  • Over the last five years, Leases for ACBM hit a ceiling of $52233.0 in Q4 2023 and a floor of $6268.0 in Q3 2021.
  • Median Leases over the past 5 years was $26308.5 (2022), compared with a mean of $27734.6.
  • Biggest five-year swings in Leases: crashed 79.6% in 2023 and later surged 411.42% in 2024.
  • Acro Biomedical's Leases stood at $50432.0 in 2021, then crashed by 49.0% to $25719.0 in 2022, then soared by 103.09% to $52233.0 in 2023, then tumbled by 48.5% to $26898.0 in 2024, then tumbled by 49.25% to $13651.0 in 2025.
  • The last three reported values for Leases were $13651.0 (Q2 2025), $20324.0 (Q1 2025), and $26898.0 (Q4 2024) per Business Quant data.